Annovis Bio
ANVS
25 hedge funds and large institutions have $10M invested in Annovis Bio in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 5 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
15% more capital invested
Capital invested by funds: $8.73M → $10M (+$1.3M)
0.4% less ownership
Funds ownership: 9.44% → 9.04% (-0.4%)
4% less funds holding
Funds holding: 26 → 25 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MFG
Merit Financial Group
Alpharetta,
Georgia
|
+$263K |
| 2 |
Bank of New York Mellon
New York
|
+$116K |
| 3 |
SIAP
Sterling Investment Advisors (Pennsylvania)
Berwyn,
Pennsylvania
|
+$72.3K |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
+$52.6K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$22.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$195K |
| 2 |
Renaissance Technologies
New York
|
-$189K |
| 3 |
LCM
Lynwood Capital Management
Toronto,
Ontario, Canada
|
-$142K |
| 4 |
EL
Essex LLC
Deer Park,
Illinois
|
-$118K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$87.7K |
ANVS Hedge Fund Activity: Q3 2022 in Review
25 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Annovis Bio (ANVS) for Q3 2022, worth a combined $10M — up 15% from $8.73M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ANVS and 4 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 6 added.
The largest buyer was Merit Financial Group, opening a new position worth an estimated $263K. The largest seller was Morgan Stanley, cutting an estimated $195K.
- 25 institutional investors held Annovis Bio (ANVS) as of Q3 2022, down from 26 in Q2 2022.
- Funds reported $10M of Annovis Bio stock for Q3 2022, up 15% quarter-over-quarter.
- 4 funds opened new Annovis Bio positions in Q3 2022 and 5 closed out, a net change of -1 holder.
- The largest Annovis Bio buyer in Q3 2022 was Merit Financial Group, an estimated $263K added.
- The largest Annovis Bio seller in Q3 2022 was Morgan Stanley, an estimated $195K sold.
Based on aggregated 13F filings for Q3 2022.